Valneva SE (INRLF)
3.29
0.00 (0.00%)
USD |
OTCM |
Aug 27, 16:00
Valneva EPS Diluted (Quarterly) : -0.1913 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.1913 |
| March 31, 2026 | -0.218 |
| December 31, 2025 | -0.3357 |
| September 30, 2025 | -0.3018 |
| June 30, 2025 | -0.0809 |
| March 31, 2025 | -0.0598 |
| December 31, 2024 | -0.2429 |
| September 30, 2024 | -0.0626 |
| June 30, 2024 | -0.1934 |
| March 31, 2024 | 0.4607 |
| December 31, 2023 | -0.2492 |
| September 30, 2023 | -0.2683 |
| June 30, 2023 | -0.1327 |
| March 31, 2023 | -0.1407 |
| December 31, 2022 | -0.3262 |
| September 30, 2022 | 0.6219 |
| June 30, 2022 | -1.424 |
| March 31, 2022 | -0.2714 |
| December 31, 2021 | 1.954 |
| September 30, 2021 | -1.882 |
| June 30, 2021 | -0.7325 |
| March 31, 2021 | -0.3643 |
| December 31, 2020 | -0.027 |
| September 30, 2020 | -0.4717 |
| June 30, 2020 | -0.2963 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.0147 |
| December 31, 2019 | 0.0083 |
| September 30, 2019 | -0.0004 |
| June 30, 2019 | -0.0887 |
| March 31, 2019 | 0.0568 |
| December 31, 2018 | 0.0809 |
| September 30, 2018 | -0.0453 |
| June 30, 2018 | -0.025 |
| March 31, 2018 | 0.0228 |
| December 31, 2017 | -0.0589 |
| September 30, 2017 | -0.047 |
| June 30, 2017 | -0.033 |
| March 31, 2017 | -0.0213 |
| December 31, 2016 | -0.0323 |
| September 30, 2016 | -0.1004 |
| June 30, 2016 | -0.5081 |
| March 31, 2016 | -0.0772 |
| December 31, 2015 | -0.0109 |
| September 30, 2015 | -0.0778 |
| June 30, 2015 | -0.1326 |
| March 31, 2015 | -0.0787 |
| December 31, 2014 | -0.2253 |
| September 30, 2014 | -0.0478 |
| June 30, 2014 | -0.1113 |
| March 31, 2014 | -0.1483 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Nicox SA | -- |
| DBV Technologies SA | -0.5804 |
| Cellectis SA | -0.2165 |
| Genfit SA | -- |
| Innate Pharma SA | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -36.28M |
| Revenue (Quarterly) | 40.62M |
| Total Expenses (Quarterly) | 76.90M |
| Enterprise Value | 725.35M |
| Gross Profit Margin (Quarterly) | 4.58% |
| Profit Margin (Quarterly) | -89.31% |
| Earnings Yield | -31.82% |
| Normalized Earnings Yield | -31.82 |